 The shares of Aurinia Pharmaceuticals Inc NASDAQ:AUPH are soaring today, after the company announced a patent settlement agreement with Sun Pharmaceutical Industries Ltd SUN related to its lupus nephritis treatment drug, Lupkynis. 